Small Molecules in Hematology

de

Éditeur :

Springer


Collection :

Recent Results in Cancer Research

Paru le : 2018-08-01

eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Lecture en ligne (streaming)
102,84

Téléchargement immédiat
Dès validation de votre commande
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description

This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL-2 inhibitor venetoclax, and the proteasome inhibitor carfilzomib. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. 
Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of precision cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. An accompanying volume addresses the use of small molecules in oncology, and the two volumes together represent the third edition of the book originally published under the same title. 


Pages
294 pages
Collection
Recent Results in Cancer Research
Parution
2018-08-01
Marque
Springer
EAN papier
9783319914381
EAN PDF
9783319914398

Informations sur l'ebook
Nombre pages copiables
2
Nombre pages imprimables
29
Taille du fichier
5274 Ko
Prix
102,84 €
EAN EPUB
9783319914398

Informations sur l'ebook
Nombre pages copiables
2
Nombre pages imprimables
29
Taille du fichier
2232 Ko
Prix
102,84 €